Advanced Search
JIANG Yujuan, ZHOU Sicheng, PEI Wei, LIANG Jianwei, ZHOU Zhixiang. Advances in Neoadjuvant Therapy for Locally Advanced Rectal Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 235-239. DOI: 10.3971/j.issn.1000-8578.2022.21.0783
Citation: JIANG Yujuan, ZHOU Sicheng, PEI Wei, LIANG Jianwei, ZHOU Zhixiang. Advances in Neoadjuvant Therapy for Locally Advanced Rectal Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 235-239. DOI: 10.3971/j.issn.1000-8578.2022.21.0783

Advances in Neoadjuvant Therapy for Locally Advanced Rectal Cancer

  • The treatment of locally advanced rectal cancer (LARC) is extremely challenging, and it is difficult to achieve satisfactory results with surgical resection alone. In recent years, the diagnosis and treatment of LARC tends to be multi-disciplinary (MDT) mode. The emerging neoadjuvant treatment strategy is a milestone. At present, the preferred treatment for LARC is neoadjuvant chemoradiotherapy combined with total mesorectal excision. This article summarizes the main treatments of LARC neoadjuvant therapy, hoping to provide reference for clinical diagnosis and treatment.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return